Glucotrack, Inc.
glucotrack.comAI Executive Summary
AI-powered analysis of 10-Q filing content
Glucotrack Inc. shows severe financial deterioration with cash declining 47% to $3.9M in Q1 2026, negative stockholders' equity indicating insolvency, and increasing debt burden. The company appears to be burning cash rapidly while developing medical devices requiring regulatory approval.
Red Flags Detected (5)
Cash declined 47% from $7.4M to $3.9M in just one quarter
Negative stockholders' equity indicating technical insolvency
Total liabilities ($5.2M) exceed total assets ($4.4M)
2 more red flags detected
Key Takeaways
Company has approximately 1-2 quarters of cash remaining at current burn rate
Medical device development requires significant regulatory approval timeline and costs
2 more takeaways
Filing Overview
What This Means
High Risk Filing: This company is showing signs of financial stress or significant operational challenges.
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.